JSA advised Intellihealth Solutions Private Limited (d/b/a Truemeds) and its Founders on its Series C funding. The round’s first close was led by Accel, followed by a second close led by Peak XV Partners, with significant participation from existing investors WestBridge and InfoEdge Ventures.
Truemeds is a leading telehealth platform which includes providing generic and substitute medicines,and is focused on enabling greater affordability in healthcare access.
The JSA transaction team was Partner Rishabh Gupta, Principal Associate Akshath Mithal, Associate Tanmayee Shriprasad Apte and Associate Saurabh Chatterji.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
